Evidence map›Paper›PMID 37341591›Full record

ArticleMicrobiology spectrum2023

Group B Streptococcus CRISPR1 Typing of Maternal, Fetal, and Neonatal Infectious Disease Isolates Highlights the Importance of CC1 in

Brice Le Gallou, Adeline Pastuszka, Coralie Lemaire, Laurent Mereghetti, Philippe Lanotte

Open access · goldAbstract read
In one paragraph

Article in Microbiology spectrum, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Automated classification of group BFrontiers in molecular biosciences · 2024
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Brice Le GallouUniversité de Tours, INRAE, Infectiologie et Santé Publique, BRMF, Tours, France.
Adeline PastuszkaUniversité de Tours, INRAE, Infectiologie et Santé Publique, BRMF, Tours, France.
Coralie LemaireUniversité de Tours, INRAE, Infectiologie et Santé Publique, BRMF, Tours, France.
Laurent MereghettiUniversité de Tours, INRAE, Infectiologie et Santé Publique, BRMF, Tours, France.
Philippe LanotteUniversité de Tours, INRAE, Infectiologie et Santé Publique, BRMF, Tours, France.ORCID 0000-0002-9993-5548
Université de Tours · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We performed a descriptive analysis of group B Streptococcus (GBS) isolates responsible for maternal and fetal infectious diseases from 2004 to 2020 at the University Hospital of Tours, France. This represents 115 isolates, including 35 isolates responsible for early-onset disease (EOD), 48 isolates responsible for late-onset disease (LOD), and 32 isolates from maternal infections. Among the 32 isolates associated with maternal infection, 9 were isolated in the context of chorioamnionitis associated with

Indexed as

ChorioamnionitisCommunicable DiseasesPremature BirthStreptococcal InfectionsAnti-Bacterial AgentsFemaleFetal DeathHumansInfant, NewbornMultilocus Sequence TypingPhylogenyPregnancyStreptococcus agalactiaeAnti-Bacterial AgentsCC1CC17CRISPRin utero deathmaternal infectionmaternofetal infectionsmolecular subtypingneonatal infectionStreptococcus agalactiaetyping

Identifiers

PMID37341591
PMCPMC10434043
OpenAlexW4381469450

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.